Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00837668 · ClinicalTrials.gov registry record
Stromal Gene Expression During Pulmonary Sarcoidosis
A clinical trial, sponsored by Ohio State University.
- Terminated
- Registry status
- 110
- Enrollment target
NCT00837668: Clinical Trial study, sponsored by Ohio State University.
NCT00837668 is a clinical trial that was terminated before completion, run by Ohio State University. The registered enrollment target is 110 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00837668 was terminated before completion, sponsored by Ohio State University.
- TERMINATED
- Registry status
- 110 participants
- Enrollment target
Study Summary
to determine the genetic pathways operating at the tissue level to cause granulomatous inflammation in the lungs and lymph nodes of patients with sarcoidosis. By so doing, we hope to identify unique genetic mechanisms which will aid in the diagnosis of sarcoidosis and will help us understand the pathogenesis of this poorly understood disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2005-04 |
| Est. Completion | 2012-02 |
Why NCT00837668 stopped before completion
NCT00837668 is an observational study that tracks outcomes without assigning an intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00837668 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00837668 about?
NCT00837668 is a clinical study titled "Stromal Gene Expression During Pulmonary Sarcoidosis". to determine the genetic pathways operating at the tissue level to cause granulomatous inflammation in the lungs and lymph nodes of patients with sarcoidosis. By so doing, we hope to identify unique genetic mechanisms which will aid in the diagnosis of sarcoidosis and will help us understand the pat...
What is the current status of trial NCT00837668?
This trial is currently terminated. The enrollment target is 110 participants. The study started on 2005-04. Estimated completion is 2012-02.
Who is sponsoring clinical trial NCT00837668?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia